Skip to main content
RemeGen Co., Ltd. logo

RemeGen Co., Ltd. — Investor Relations & Filings

Ticker · 9995 ISIN · CNE1000048G6 LEI · 300300M9HCX4TFAD4I10 HKEX Manufacturing
Open in API
Filings indexed 1,624 across all filing types
Latest filing 2024-03-27 Governance Information
Country CN China
Listing HKEX 9995

About RemeGen Co., Ltd.

http://www.remegen.com

RemeGen Co., Ltd. is a biopharmaceutical company dedicated to the discovery, development, production, and commercialization of innovative biological drugs. The company focuses on creating first-in-class and best-in-class therapeutics to address significant unmet clinical needs, particularly in the critical therapeutic areas of autoimmune diseases, oncology, and ophthalmology. RemeGen utilizes proprietary technology platforms capable of discovering, screening, and developing new molecules and efficiently optimizing production processes. Its pipeline includes a series of innovative biologics, such as Telitacicept, and features 8 clinical pipelines, over 40 clinical trials, and more than 600 patent applications, demonstrating a strong commitment to R&D and innovation in biopharmaceuticals.

Recent filings

Filing Released Lang Actions
ANNOUNCEMENT-AMENDMENTS TO THE ARTICLES OF ASSOCIATION
Governance Information Classification · 95% confidence The document is an announcement regarding amendments to the Articles of Association of RemeGen Co., Ltd. It details changes in the registered capital and share structure following the attribution of restricted shares under an incentive scheme. The document references approvals by the Board and shareholders, and it is made pursuant to a listing rule. It includes a comparison table of the original and amended articles. The document is not a full report but an announcement of changes to governance documents (Articles of Association). It does not contain financial statements or detailed financial analysis. It is not a report publication announcement since it contains substantive amendment details, not just a notice of publication. The content fits best under Governance Information (CGR), as it relates to internal rules and governance practices of the company.
2024-03-27 English
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2023
Annual Report Classification · 95% confidence The document is titled 'ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2023' and contains detailed consolidated financial results for the full fiscal year 2023, including revenue, profit/loss, expenses, and cash balances. It also includes extensive business highlights, product pipeline updates, clinical trial progress, and management discussion and analysis. The length is substantial (15,000 characters), and the content includes comprehensive financial data and operational review for the full year, which aligns with the characteristics of an Annual Report (10-K). There is no indication that this is merely an announcement of a report or a certification letter. Therefore, the document should be classified as an Annual Report (10-K). FY 2023
2024-03-27 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2024-03-22 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2024-03-22 English
DATE OF BOARD MEETING
Report Publication Announcement Classification · 95% confidence The document is a short announcement from Overseas Chinese Town (Asia) Holdings Limited stating the date of a forthcoming Board meeting to approve the final results for the year ended 31 December 2023 and to consider the payment of a final dividend. It does not contain any financial data or detailed report content itself. The length is only 1487 characters, which is quite short and typical for an announcement. It is clearly an announcement about an upcoming event related to financial results, not the results or report itself. Therefore, according to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA) type filing, as it announces the timing of the report approval and dividend consideration but does not include the report or results themselves.
2024-03-18 English
Notification Letter and Reply Form to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
Report Publication Announcement Classification · 95% confidence The document is a letter dated 15 March 2024 from Overseas Chinese Town (Asia) Holdings Limited addressed to non-registered shareholders. It informs shareholders about the company's adoption of electronic dissemination of corporate communications in compliance with the Hong Kong Stock Exchange Listing Rules (Rule 2.07A). The letter explains the types of corporate communications covered, including annual reports, interim reports, notices of meetings, circulars, and proxy forms. It also provides instructions for shareholders to receive printed copies if desired and includes a reply form for shareholders to request printed communications. The document does not contain any financial data, financial statements, or detailed report content. Instead, it is an announcement about the method of distributing corporate communications going forward. The document is relatively short (about 10,981 characters) and serves as a notification rather than the report itself. Therefore, according to the "Menu vs Meal" rule, this document is best classified as a Report Publication Announcement (RPA), since it announces the availability and method of accessing corporate communications rather than being the communications themselves.
2024-03-15 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.